Z-360, a Novel Cholecystokinin-2/Gastrin Receptor Antagonist, Inhibits Gemcitabine-Induced Expression of the Vascular Endothelial Growth Factor Gene in Human Pancreatic Cancer Cells-Reference-Cited by-同舟云学术

Z-360, a Novel Cholecystokinin-2/Gastrin Receptor Antagonist, Inhibits Gemcitabine-Induced Expression of the Vascular Endothelial Growth Factor Gene in Human Pancreatic Cancer Cells

Published:2010 Issue:2 Volume:33 Page:216-222
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kobayashi Nobuyoshi¹,Seto Koichi¹,Orikawa Yuki¹,Hamano Hiroki¹,Yoshinaga Koji¹,Takei Mineo¹

Affiliation:

1. Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/33/2/33_2_216/_pdf

Reference33 articles.

1. Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro

2. 2) Meyer T., Caplin M., Palmer D., Valle J. W., Larvin M., Waters J., Coxon F., Borbath I., Peeters M., Nagano E., Kato H., J. Clin. Oncol., 26, suppl., 4636 (2008).

3. Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models

4. Growth-promoting action of gastrin on human colonic and gastric tumour cells cultured in vitro

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological behavior of 1,4-benzodiazepines and 1,4-benzothiazepines;Benzodiazepine-Based Drug Discovery;2022

2. Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression;Investigational New Drugs;2019-05-14

3. Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway;International Reviews of Immunology;2014-09-12

4. Cholecystokinin and gastrin receptors targeting in gastrointestinal cancer;Surgical Oncology;2012-12

5. Somatic Mutations in CCK2R Alter Receptor Activity that Promote Oncogenic Phenotypes;Molecular Cancer Research;2012-04-19